• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢性胰岛素抵抗评分与非酒精性脂肪性肝病患者发生进展性肝纤维化呈负相关。

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.

机构信息

Department of Family Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul 01830, Korea.

Department of Medicine, Hanyang University Graduate School of Medicine, Seoul 04763, Korea.

出版信息

Nutrients. 2022 Jul 24;14(15):3039. doi: 10.3390/nu14153039.

DOI:10.3390/nu14153039
PMID:35893894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330359/
Abstract

We determined the relationships between metabolic score for IR (METS-IR), triglyceride-glucose (TyG) index, and homeostatic model assessment for IR (HOMA-IR) and incident advanced liver fibrosis (ALF) and assessed the abilities of the three IR indicators to predict ALF in patients with non-alcoholic fatty liver disease (NAFLD) in adults with NAFLD who were aged 40-69 years old. Among 2218 participants with NAFLD at baseline, the areas under the receiver operating characteristic curve for predicting ALF of the METS-IR was 0.744 (0.679-0.810), significantly higher than that of TyG index (0.644 (0.569-0.720)) or that of HOMA-IR (0.633 (0.556-0.710)). Among 1368 patients with NAFLD and without ALF at baseline, 260 (19.0%) patients with NAFLD progressed to ALF during the 16-year follow-up period. Multivariable Cox proportional hazard regression analysis revealed that the adjusted hazard ratio (95% confidence interval) for incident ALF in the highest tertiles of METS-IR, TyG index, and HOMA-IR compared with the lowest tertile of each IR indicator were 0.5 (0.36-0.91), 0.7 (0.49-1.00), and 1.01 (0.71-1.42), respectively. METS-IR was inversely associated with ALF in patients with NAFLD, which cautiously suggests that the risk of ALF may need to be evaluated when metabolic parameters improve in individuals with NAFLD.

摘要

我们确定了胰岛素抵抗代谢评分(METS-IR)、甘油三酯-葡萄糖(TyG)指数和胰岛素抵抗的稳态模型评估(HOMA-IR)与非酒精性脂肪性肝病(NAFLD)患者发生晚期肝纤维化(ALF)的关系,并评估了这三种胰岛素抵抗指标在年龄 40-69 岁的 NAFLD 患者中预测 ALF 的能力。在基线时有 NAFLD 的 2218 名参与者中,METS-IR 预测 ALF 的受试者工作特征曲线下面积为 0.744(0.679-0.810),明显高于 TyG 指数(0.644(0.569-0.720))或 HOMA-IR(0.633(0.556-0.710))。在基线时无 ALF 的 1368 名 NAFLD 患者中,有 260(19.0%)名 NAFLD 患者在 16 年的随访期间进展为 ALF。多变量 Cox 比例风险回归分析显示,与每个 IR 指标的最低三分位相比,METS-IR、TyG 指数和 HOMA-IR 的最高三分位发生 ALF 的调整后的危险比(95%置信区间)分别为 0.5(0.36-0.91)、0.7(0.49-1.00)和 1.01(0.71-1.42)。METS-IR 与 NAFLD 患者的 ALF 呈负相关,这谨慎地表明,当 NAFLD 个体的代谢参数改善时,可能需要评估 ALF 的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb44/9330359/6c546541f5dc/nutrients-14-03039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb44/9330359/62e517848b94/nutrients-14-03039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb44/9330359/b04e89bcc60f/nutrients-14-03039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb44/9330359/6c546541f5dc/nutrients-14-03039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb44/9330359/62e517848b94/nutrients-14-03039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb44/9330359/b04e89bcc60f/nutrients-14-03039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb44/9330359/6c546541f5dc/nutrients-14-03039-g003.jpg

相似文献

1
Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.代谢性胰岛素抵抗评分与非酒精性脂肪性肝病患者发生进展性肝纤维化呈负相关。
Nutrients. 2022 Jul 24;14(15):3039. doi: 10.3390/nu14153039.
2
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.代谢评分对胰岛素抵抗预测韩国成年人非酒精性脂肪性肝病发病的作用。
Clin Mol Hepatol. 2022 Oct;28(4):814-826. doi: 10.3350/cmh.2022.0099. Epub 2022 Jun 9.
3
Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.甘油三酯葡萄糖指数优于稳态模型评估胰岛素抵抗预测韩国成年人非酒精性脂肪肝。
Endocrinol Metab (Seoul). 2019 Jun;34(2):179-186. doi: 10.3803/EnM.2019.34.2.179.
4
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.非酒精性脂肪性肝病/代谢相关脂肪性肝病和肝纤维化的早期诊断潜在筛查指标:甘油三酯葡萄糖指数相关参数。
Front Endocrinol (Lausanne). 2022 Sep 2;13:951689. doi: 10.3389/fendo.2022.951689. eCollection 2022.
5
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.与非糖尿病人群中非酒精性脂肪性肝病相关的胰岛素抵抗标志物。
Sci Rep. 2023 Nov 22;13(1):20470. doi: 10.1038/s41598-023-47269-4.
6
The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.甘油三酯-葡萄糖指数与非酒精性脂肪性肝病患者肝脂肪变性严重程度和肝纤维化的相关性:中国成年人的横断面研究。
Lipids Health Dis. 2020 Oct 7;19(1):218. doi: 10.1186/s12944-020-01393-6.
7
Multi-dimensional comparison of abdominal obesity indices and insulin resistance indicators for assessing NAFLD.多维度比较腹型肥胖指标与胰岛素抵抗指标用于评估非酒精性脂肪肝。
BMC Public Health. 2024 Aug 9;24(1):2161. doi: 10.1186/s12889-024-19657-6.
8
Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.比较甘油三酯-葡萄糖指数和 HOMA-IR 预测代谢综合征的患病率和发生率。
Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):596-604. doi: 10.1016/j.numecd.2021.11.017. Epub 2021 Dec 7.
9
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
10
Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.非肥胖血脂正常人群中甘油三酯-葡萄糖-体重指数与非酒精性脂肪肝的相关性:基于前瞻性队列研究的二次分析。
Lipids Health Dis. 2020 Oct 28;19(1):229. doi: 10.1186/s12944-020-01409-1.

引用本文的文献

1
ISI as a potential predictor of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.胰岛素敏感指数作为2型糖尿病患者代谢功能障碍相关脂肪性肝病的潜在预测指标。
Front Med (Lausanne). 2025 Aug 29;12:1623808. doi: 10.3389/fmed.2025.1623808. eCollection 2025.
2
HOMA-IR, an independent predictor of advanced liver fibrosis in metabolic-dysfunction associated fatty liver disease: a cross-sectional study in Egyptian patients.HOMA-IR是代谢功能障碍相关脂肪性肝病中晚期肝纤维化的独立预测指标:一项针对埃及患者的横断面研究。
Sci Rep. 2025 Aug 24;15(1):31098. doi: 10.1038/s41598-025-15425-7.
3

本文引用的文献

1
The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018.胰岛素抵抗对美国非酒精性脂肪性肝病成人肝纤维化的影响:NHANES 2017 至 2018 年。
Endocrinol Metab (Seoul). 2022 Jun;37(3):455-465. doi: 10.3803/EnM.2022.1434. Epub 2022 Jun 21.
2
Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.非肥胖中国人群胰岛素抵抗指数代谢评分与非酒精性脂肪性肝病的剂量-反应关系:基于人群队列研究的回顾性证据。
Dis Markers. 2022 Feb 23;2022:4930355. doi: 10.1155/2022/4930355. eCollection 2022.
3
Nonlinear relationship between body fat percentage and NAFLD mediated by METS-IR: threshold effects and subgroup differences.
由代谢综合征胰岛素抵抗(METS-IR)介导的体脂百分比与非酒精性脂肪性肝病(NAFLD)之间的非线性关系:阈值效应和亚组差异。
Sci Rep. 2025 Jul 10;15(1):24917. doi: 10.1038/s41598-025-10765-w.
4
Comparisons of various insulin resistance indices for new-onset metabolic syndrome before midlife: The CHIEF cohort study, 2014-2020.中年期前新发代谢综合征的各种胰岛素抵抗指数比较:2014 - 2020年CHIEF队列研究
World J Diabetes. 2025 May 15;16(5):101840. doi: 10.4239/wjd.v16.i5.101840.
5
Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea.非胰岛素类胰岛素抵抗替代标志物与代谢功能障碍相关脂肪性肝病肝脏相关结局的关联:韩国一项全国性队列研究
BMC Gastroenterol. 2025 Apr 18;25(1):274. doi: 10.1186/s12876-025-03877-0.
6
Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017-2020.非酒精性脂肪性肝病中肝纤维化与胰岛素抵抗指标的相关性:一项基于2017 - 2020年美国国家健康与营养检查调查(NHANES)的横断面研究
Front Endocrinol (Lausanne). 2025 Jan 31;16:1514093. doi: 10.3389/fendo.2025.1514093. eCollection 2025.
7
Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study of NHANES 2017-2020.美国代谢相关脂肪性肝病成人患者甘油三酯-葡萄糖指数与肝纤维化的关联:一项基于2017-2020年美国国家健康与营养检查调查(NHANES)的横断面研究
BMC Gastroenterol. 2025 Jan 2;25(1):3. doi: 10.1186/s12876-024-03579-z.
8
Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial.口服胰岛素可减轻代谢功能障碍相关脂肪性肝炎和2型糖尿病患者的肝纤维化并减少肝脏脂肪变性:II期随机、安慰剂对照可行性临床试验结果
Gastro Hep Adv. 2023 Dec 7;3(3):417-425. doi: 10.1016/j.gastha.2023.11.016. eCollection 2024.
9
Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中果糖代谢的调节。
Biomolecules. 2024 Jul 13;14(7):845. doi: 10.3390/biom14070845.
10
Negative correlation between metabolic score for insulin resistance index and testosterone in male adults.成年男性中胰岛素抵抗指数的代谢评分与睾酮之间呈负相关。
Diabetol Metab Syndr. 2024 May 23;16(1):113. doi: 10.1186/s13098-024-01353-5.
Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study.
非糖尿病非酒精性脂肪性肝病患者胰岛素抵抗指数变化与肝纤维化风险:康伯三星健康研究。
Endocrinol Metab (Seoul). 2021 Oct;36(5):1016-1028. doi: 10.3803/EnM.2021.1110. Epub 2021 Oct 21.
4
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy.肝纤维化:治疗靶点与药物治疗进展
Front Cell Dev Biol. 2021 Sep 21;9:730176. doi: 10.3389/fcell.2021.730176. eCollection 2021.
5
Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.非糖尿病非酒精性脂肪性肝病患者纤维化进展与胰岛素抵抗相关的基线稳态模型评估:一项队列研究。
PLoS One. 2021 Aug 25;16(8):e0255535. doi: 10.1371/journal.pone.0255535. eCollection 2021.
6
Current and Emerging Approaches for Hepatic Fibrosis Treatment.肝纤维化治疗的当前及新出现的方法
Gastroenterol Res Pract. 2021 Jul 16;2021:6612892. doi: 10.1155/2021/6612892. eCollection 2021.
7
Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity.非酒精性脂肪性肝病伴或不伴病态肥胖患者非侵袭性纤维化评分的表现。
Int J Obes (Lond). 2021 Oct;45(10):2197-2204. doi: 10.1038/s41366-021-00881-8. Epub 2021 Jun 24.
8
Global Epidemiology of Chronic Liver Disease.慢性肝病的全球流行病学
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):365-370. doi: 10.1002/cld.1061. eCollection 2021 May.
9
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment.非酒精性脂肪性肝病中的肝纤维化:从肝活检到诊断和治疗中的非侵入性生物标志物
Front Med (Lausanne). 2021 Apr 14;8:615978. doi: 10.3389/fmed.2021.615978. eCollection 2021.
10
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease.胰岛素抵抗和糖尿病在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2020 May 29;21(11):3863. doi: 10.3390/ijms21113863.